Quantbot Technologies’s Juno Therapeutics, Inc. JUNO Stock Holding History

Quantbot Technologies’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,793	Closed	-$81K	–	1680
2017 Q4	$81K	Buy	+1,793	New	+$89.4K	0.01%	885
2017 Q2	–	Sell	-2,257	Closed	-$50K	–	1526
2017 Q1	$50K	Buy	+2,257	New	+$48.4K	0.01%	916
2016 Q4	–	Sell	-1,061	Closed	-$31K	–	1510
2016 Q3	$31K	Buy	+1,061	New	+$33K	﹤0.01%	910
2016 Q1	–	Sell	-448	Closed	-$19K	–	1544
2015 Q4	$19K	Buy	+448	New	+$22.2K	﹤0.01%	934
2015 Q3	–	Sell	-4,000	Closed	-$213K	–	1579
2015 Q2	$213K	Buy	+4,000	New	+$212K	0.04%	429

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Quantbot Technologies's JUNO Position: Q1 2018 in Review

Quantbot Technologies sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 1,793 shares — an estimated $81K sold.

Quantbot Technologies first reported a position in JUNO in Q2 2015 and held it in 5 quarters. The position peaked at $213K in Q2 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Quantbot Technologies reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Quantbot Technologies sold 1,793 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $81K.
Quantbot Technologies first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 5 quarters.
Quantbot Technologies's Juno Therapeutics, Inc. position peaked at $213K in Q2 2015.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Quantbot Technologies's 13F filing for Q1 2018, filed 11 May 2018.